Article
Paraquat (Gramoxone®) Parkinson's Class Action Certification Upheld On Appeal In British Columbia
Since 2021, Siskinds LLP has represented the plaintiffs in proposed paraquat (Gramoxone®) class actions across Canada, alleging that paraquat exposure is associated with an increased risk of developing Parkinson's disease.
Siskinds LLP